APA
Peloquin C. A., Velásquez G. E., Lecca L., Calderón R. I., Coit J., Milstein M., Osso E., Jimenez J., Tintaya K., Garavito E. S., Vasquez D. V., Mitnick C. D. & Davies G. (092017). Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". : Antimicrobial agents and chemotherapy.
Chicago
Peloquin C A, Velásquez G E, Lecca L, Calderón R I, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Garavito E Sanchez, Vasquez D Vargas, Mitnick C D and Davies G. 092017. Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". : Antimicrobial agents and chemotherapy.
Harvard
Peloquin C. A., Velásquez G. E., Lecca L., Calderón R. I., Coit J., Milstein M., Osso E., Jimenez J., Tintaya K., Garavito E. S., Vasquez D. V., Mitnick C. D. and Davies G. (092017). Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". : Antimicrobial agents and chemotherapy.
MLA
Peloquin C A, Velásquez G E, Lecca L, Calderón R I, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Garavito E Sanchez, Vasquez D Vargas, Mitnick C D and Davies G. Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". : Antimicrobial agents and chemotherapy. 092017.